In Vitro-In Vivo Correlation of Buprenorphine Transdermal Systems Under Normal and Elevated Skin Temperature
- PMID: 37095369
- DOI: 10.1007/s11095-023-03487-z
In Vitro-In Vivo Correlation of Buprenorphine Transdermal Systems Under Normal and Elevated Skin Temperature
Abstract
Purpose: Application of external heat using a heating pad over buprenorphine transdermal system, Butrans® has been shown to increase systemic levels of buprenorphine in human volunteers. The purpose of this study was to perform in vitro permeation studies at normal as well as elevated temperature conditions to evaluate the correlation of in vitro data with the existing in vivo data.
Methods: In vitro permeation tests (IVPT) were performed on human skin from four donors. The IVPT study design was harmonized to a previously published clinical study design and skin temperature was maintained at either 32 ± 1 °C or 42 ± 1 °C to mimic normal and elevated skin temperature conditions, respectively.
Results: IVPT studies on human skin were able to demonstrate heat induced enhancement in flux and cumulative amount of drug permeated from Butrans® which was reasonably consistent with the corresponding enhancement observed in vivo. Level A in vitro-in vivo correlation (IVIVC) was established using unit impulse response (UIR) based deconvolution method for both baseline and heat arms of the study. The percent prediction error (%PE) calculated for AUC and Cmax values was less than 20%.
Conclusions: The studies indicated that IVPT studies performed under the same conditions as those of interest in vivo may be useful for comparative evaluation of the effect of external heat on transdermal delivery system (TDS). Further research may be warranted to evaluate factors, beyond cutaneous bioavailability (BA) assessed using an IVPT study, that can influence plasma exposure in vivo for a given drug product.
Keywords: buprenorphine; drug permeation, heat; in vitro – in vivo correlation; temperature.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
In vitro-in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence of transient heat application.J Control Release. 2018 Jan 28;270:76-88. doi: 10.1016/j.jconrel.2017.11.034. Epub 2017 Nov 22. J Control Release. 2018. PMID: 29175139
-
Evaluation of in vitro/in vivo correlations for three fentanyl transdermal delivery systems using in vitro skin permeation testing and human pharmacokinetic studies under the influence of transient heat application.J Control Release. 2022 Feb;342:134-147. doi: 10.1016/j.jconrel.2021.11.030. Epub 2021 Nov 25. J Control Release. 2022. PMID: 34838928
-
On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with Nicotine and Fentanyl.Pharm Res. 2017 Sep;34(9):1817-1830. doi: 10.1007/s11095-017-2189-0. Epub 2017 Jun 12. Pharm Res. 2017. PMID: 28608140
-
Heat effects on drug delivery across human skin.Expert Opin Drug Deliv. 2016;13(5):755-68. doi: 10.1517/17425247.2016.1136286. Epub 2016 Jan 25. Expert Opin Drug Deliv. 2016. PMID: 26808472 Free PMC article. Review.
-
In vitro permeation testing for the evaluation of drug delivery to the skin.Eur J Pharm Sci. 2024 Oct 1;201:106873. doi: 10.1016/j.ejps.2024.106873. Epub 2024 Aug 8. Eur J Pharm Sci. 2024. PMID: 39121921 Review.
Cited by
-
Buprenorphine Use for Analgesia in Palliative Care.Pharmacy (Basel). 2024 May 13;12(3):78. doi: 10.3390/pharmacy12030078. Pharmacy (Basel). 2024. PMID: 38804470 Free PMC article.
References
-
- Shin SH, Thomas S, Raney SG, Ghosh P, Hammell DC, El-Kamary SS, Chen WH, Billington MM, Hazem HE, Stinchcomb AL. In vitro – in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence of transient heat application. J Control Release. 2018;270:76–88. - DOI - PubMed
-
- Grissinger M. Fentanyl transdermal patches: more protection needed for patients and their families. P T. 2009;34(7):343–90. - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources